Base de dados : MEDLINE
Pesquisa : C23.888.144.243 [Categoria DeCS]
Referências encontradas : 4 [refinar]
Mostrando: 1 .. 4   no formato [Detalhado]

página 1 de 1

  1 / 4 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:11023988
[Au] Autor:Vassileva G; Huwyler L; Poirier K; Agellon LB; Toth MJ
[Ad] Endereço:Novartis Institute for Biomedical Research, Summit, New Jersey 07901, USA.
[Ti] Título:The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice.
[So] Source:FASEB J;14(13):2040-6, 2000 Oct.
[Is] ISSN:0892-6638
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The intestinal fatty acid binding protein (I-FABP) belongs to a family of 15 kDa clamshell-like proteins that are found in many different tissues. So far, nine types have been identified. Their primary structures are highly conserved between species but somewhat less so among the different types. The function of these proteins, many of which are highly expressed, is not well understood. Their ability to bind lipid ligands suggests a role in lipid metabolism, but direct evidence for this idea is still lacking. We tested the hypothesis that I-FABP serves an essential role in the assimilation of dietary fatty acids by disrupting its gene (Fabpi) in the mouse. We discovered that Fabpi-/- mice are viable, but they display alterations in body weight and are hyperinsulinemic. Male Fabpi-/- mice had elevated plasma triacylglycerols and weighed more regardless of the dietary fat content. In contrast, female Fabpi-/- mice gained less weight in response to a high-fat diet. The results clearly demonstrate that I-FABP is not essential for dietary fat absorption. We propose that I-FABP functions as a lipid-sensing component of energy homeostasis that alters body weight gain in a gender-specific fashion.
[Mh] Termos MeSH primário: Proteínas de Transporte/metabolismo
Gorduras na Dieta/metabolismo
Absorção Intestinal
Proteínas de Neoplasias
Proteínas do Tecido Nervoso
[Mh] Termos MeSH secundário: Animais
Glicemia/análise
Alterações do Peso Corporal
Proteínas de Transporte/genética
Proteína 7 de Ligação a Ácidos Graxos
Proteínas de Ligação a Ácido Graxo
Feminino
Insulina/sangue
Lipídeos/sangue
Masculino
Camundongos
Camundongos Mutantes
Fatores Sexuais
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Blood Glucose); 0 (Carrier Proteins); 0 (Dietary Fats); 0 (Fabp5 protein, mouse); 0 (Fabp7 protein, mouse); 0 (Fatty Acid-Binding Protein 7); 0 (Fatty Acid-Binding Proteins); 0 (Insulin); 0 (Lipids); 0 (Neoplasm Proteins); 0 (Nerve Tissue Proteins)
[Em] Mês de entrada:0011
[Cu] Atualização por classe:161124
[Lr] Data última revisão:
161124
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:001012
[St] Status:MEDLINE


  2 / 4 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:10960507
[Au] Autor:Yuan CS; Attele AS; Zhang L; Lynch JP; Xie JT; Shi ZQ
[Ad] Endereço:Committee on Clinical Pharmacology, The Pritzker School of Medicine, The University of Chicago, Illinois 60637, USA.
[Ti] Título:Leptin reduces body weight gain in neonatal rats.
[So] Source:Pediatr Res;48(3):380-3, 2000 Sep.
[Is] ISSN:0031-3998
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Leptin (OB protein) elicits a neuroendocrine response to starvation and states of nutritional abundance to stabilize the proportion of body fat. Leptin has dramatic effects on food intake and energy expenditure in adult and juvenile rodents. However, whether the neonatal period is associated with the development of an effective leptin feedback system is still not known. In this study, we evaluated the effects of peripherally administered leptin on body weight changes in neonatal rats during the early suckling period (from birth to 10 d). Our results show that daily i.p. injections of leptin (0.3 microg/g and 1.0 microg/g) to neonatal rats led to a significant reduction in weight gain over 10 d compared with the control group (p < 0.01 and p < 0.01, respectively). Concomitant with a reduction in weight gain, retroperitoneal fat pad weight also significantly decreased in the leptin-treated group. Our data indicate that the potential for energy balance regulation by leptin occurs in the first day after birth. In addition, we also observed that 3 d after discontinuing leptin treatment, the body weight as well as the fat pad weight of leptin-treated pups returned to the control level. Our results demonstrate that leptin reduces body weight gain in neonatal rats.
[Mh] Termos MeSH primário: Peso Corporal/efeitos dos fármacos
Leptina/administração & dosagem
[Mh] Termos MeSH secundário: Animais
Animais Recém-Nascidos
Alterações do Peso Corporal
Injeções Intraperitoneais
Ratos
Ratos Sprague-Dawley
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Leptin)
[Em] Mês de entrada:0102
[Cu] Atualização por classe:061115
[Lr] Data última revisão:
061115
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:000829
[St] Status:MEDLINE


  3 / 4 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:10643834
[Au] Autor:Jernström H; Barrett-Connor E
[Ad] Endereço:Department of Family and Preventive Medicine, University of California at San Diego, La Jolla, USA.
[Ti] Título:Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study.
[So] Source:J Womens Health Gend Based Med;8(10):1265-72, 1999 Dec.
[Is] ISSN:1524-6094
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Postmenopausal overweight women have an increased risk of breast cancer. The link between obesity and breast cancer could be mediated through hyperinsulinemia. Insulin and insulin-like growth factor-1 (IGF-1) stimulate mammary cell proliferation in vitro, and cell proliferation is directly linked to the risk of breast cancer. Our objective was to investigate the relationship between breast cancer and body composition, IGF-1, proinsulin, C-peptide, and fasting insulin. A case-control study was conducted of 438 community-dwelling women aged 53-90 years in 1992-1994 who had no history of cancer at the baseline visit in 1972-1974. Women were excluded who were using estrogen replacement therapy (ERT) or tamoxifen at the 1992-1994 visit, when IGF-1, proinsulin, fasting insulin, and C-peptide levels were measured. Prior ERT, alcohol and tobacco use, exercise, and reproductive history were recorded. Weight, height, and waist/hip ratio were measured. The 45 women with breast cancer had similar baseline body mass indices to the 393 women without breast cancer but had gained significantly more weight between the baseline visit in 1972-1974 and 1992-1994, (age-adjusted relative risk [RR] 1.05/kg, 95% confidence interval [CI] 1.01-1.09, p = 0.016). Proinsulin, fasting insulin, and C-peptide were each significantly positively correlated with both current weight and weight gain. However, levels of these hormones and IGF-1 did not differ significantly between women with and without breast cancer (all 95% CI within 0.996-1.004). Past ERT was significantly more common among women with breast cancer (p = 0.015), and duration of use was significantly longer (age-adjusted RR 1.13 per year of use, 95% CI 1.08-1.18, p = 0.000). The risk of breast cancer was significantly increased in women who had gained weight or used ERT. This increased risk was not associated with circulating levels of IGF-1, fasting insulin, proinsulin, or C-peptide.
[Mh] Termos MeSH primário: Alterações do Peso Corporal
Neoplasias da Mama/sangue
Peptídeo C/sangue
Fator de Crescimento Insulin-Like I/metabolismo
Insulina/sangue
Obesidade/sangue
Proinsulina/sangue
[Mh] Termos MeSH secundário: Idoso
Idoso de 80 Anos ou mais
Neoplasias da Mama/etiologia
Estudos de Casos e Controles
Terapia de Reposição de Estrogênios
Feminino
Seguimentos
Seres Humanos
Estilo de Vida
Meia-Idade
Obesidade/complicações
Fatores de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T; RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
[Nm] Nome de substância:
0 (C-Peptide); 0 (Insulin); 67763-96-6 (Insulin-Like Growth Factor I); 9035-68-1 (Proinsulin)
[Em] Mês de entrada:0002
[Cu] Atualização por classe:111117
[Lr] Data última revisão:
111117
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:000122
[St] Status:MEDLINE


  4 / 4 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
[PMID]:10591335
[Au] Autor:Fine JT; Colditz GA; Coakley EH; Moseley G; Manson JE; Willett WC; Kawachi I
[Ad] Endereço:Department of Health and Social Behavior, Harvard School of Public Health, Boston, Mass, USA.
[Ti] Título:A prospective study of weight change and health-related quality of life in women.
[So] Source:JAMA;282(22):2136-42, 1999 Dec 08.
[Is] ISSN:0098-7484
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:CONTEXT: The mean body weight of US adults increased by 3.6 kg (7.6 lb) during the past 15 years, but few studies exist that examine the impact of such weight change on functional health status. OBJECTIVE: To investigate, prospectively, the association between weight change and health-related quality of life in women. DESIGN AND SETTING: Nurses' Health Study, a 4-year prospective observational study from 1992 to 1996, using the Medical Outcomes Study Short-Form 36 Health Status Survey (a self-administered 36-item questionnaire) to measure quality of life. PARTICIPANTS: A cohort of 40098 women (from 46-71 years old in 1992) grouped according to 3 patterns of weight change over the 4-year period: women whose weight remained within 2.25 kg (5 lb) of their baseline weight, women who lost 2.25 kg (5 lb) or more, and women who gained 2.25 kg (5 lb) or more. MAIN OUTCOME MEASURES: Change in scores on 7 health-related quality-of-life dimensions: physical functioning, vitality, bodily pain, limitations in role functioning due to emotional or physical problems, social functioning, and mental health, measured by the Short-Form 36 Health Status Survey. RESULTS: A total of 15602 women (39%) maintained their weight, 15160 (38%) gained between 2.25 and 9.0 kg (5-20 lb), and 6667 (17%) lost between 2.25 and 9.0 kg (5-20 lb). Weight gain was associated with decreased physical function and vitality, and increased bodily pain regardless of baseline weight. For example, the odds ratio for developing role limitations due to physical problems was 2.05 (95% confidence interval, 1.69-2.49) for the leanest women who gained 9.0 kg (20 lb) or more. Weight loss in overweight women was associated with improved physical function and vitality as well as decreased bodily pain. Weight change was more strongly associated with physical rather than mental health. The impact of weight change, especially weight gain, was just as strong in women 65 years and older as in women younger than 65 years. CONCLUSIONS: These longitudinal data support current US guidelines for women of all body mass index levels to avoid weight gain. Weight maintenance and, in cases of overweight, weight loss are desirable and likely to be beneficial for physical function, vitality, and bodily pain.
[Mh] Termos MeSH primário: Alterações do Peso Corporal
Nível de Saúde
Qualidade de Vida
[Mh] Termos MeSH secundário: Idoso
Índice de Massa Corporal
Feminino
Inquéritos Epidemiológicos
Seres Humanos
Estudos Longitudinais
Meia-Idade
Estudos Prospectivos
Estados Unidos/epidemiologia
Ganho de Peso
Perda de Peso
Saúde da Mulher
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
[Em] Mês de entrada:9912
[Cu] Atualização por classe:161017
[Lr] Data última revisão:
161017
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:991211
[St] Status:MEDLINE



página 1 de 1
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde